Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
Nanox Expands U.S. Distribution Network Through New England Partnership

Expands Nanox’s growing U.S. distribution network with a leading New England-based medical imaging provider Nano-X Imaging Ltd. (“Nanox&rdqu...

September 08, 2026 | Tuesday | News
ONWARD Medical Implants First ARC-IM System in EIGER Study to Advance Mobility Recovery After Spinal Cord Injury

ONWARD Medical N.V., the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence, announces ...

September 04, 2026 | Friday | News
Teva and Trump Administration Commit to Lowering Costs of Select Medicines for U.S. Medicaid Patients

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...

September 02, 2026 | Wednesday | News
Revolution Medicines Wins FDA Approval for RASONQUE in Metastatic Pancreatic Cancer

Revolution Medicines, Inc., a global commercial-stage oncology company dedicated to discovering, developing and delivering innovative medicines for patie...

August 28, 2026 | Friday | News
Smith+Nephew Introduces FLOW FLEXTEND COBLATION Wand for Hip Procedures

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces a breakthrough in RF resection technology for hip with its new FLOW FLE...

August 19, 2026 | Wednesday | News
GE HealthCare Launches Invenia ABUS Prime and ABUS StreamVue for Dense Breast Screening

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles...

August 05, 2026 | Wednesday | News
NeuroPace to Work with FDA After PMA Supplement for IGE Indication Receives Non-Approvable Letter

-- Company received communication from FDA indicating that the PMA Supplement for idiopathic generalized epilepsy is not approvable in its current form...

July 30, 2026 | Thursday | News
Novanta Completed Acquisition of Riverpoint Medical to Expand Surgical Consumables Portfolio

Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipme...

July 29, 2026 | Wednesday | News
Wellumio Secures $9.75M to Advance Portable Stroke Imaging Technology

Australian medtech investor Bioshore Ventures and US neurotechnology investor Jumpspace Ventures join Wellumio's oversubscribed pre-Series A round in the f...

July 28, 2026 | Tuesday | News
Leica Biosystems to Acquire StatLab Medical Products to Expand Pathology Diagnostics Portfolio

Leica Biosystems, an operating company of Danaher (the "Company"), and a global leader in anatomic pathology solutions advancing precision cancer diagnosti...

July 16, 2026 | Thursday | News
Danaher’s Abcam Partners with EpiCypher to Advance Epigenomics Research

Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CU...

July 09, 2026 | Thursday | News
Thubrikar Aortic Valve Partners with MAC’s MEDICAL Group to Advance CE Mark Trial for Optimum TAVI System

  -Thubrikar Aortic Valve, Inc. announced its partnership with MAC’s MEDICAL Group, a distributor of cardiovascular devices in Europe, and MAC&...

June 30, 2026 | Tuesday | News
Smith+Nephew Achieves First Clinical Cases with Next-Generation CORI XT Handheld Robotics Platform

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, announces the completion of the first clinical cases performed using the nextâ€...

June 10, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close